SCHEMBL5166429

SCHEMBL5166429

[O]C(=O)Oc1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616681 0.84 MMP1 (0.51)
SCHEMBL1036006 0.82
SCHEMBL1254648 0.82
SCHEMBL541057 0.80
SCHEMBL29276385 0.80 MMP1 (0.57)
Benzene SCHEMBL29129489 0.80 MMP1 (0.49)
SCHEMBL699939 0.80
SCHEMBL7515256 0.80 MMP1 (0.49)
SCHEMBL2941993 0.80
SCHEMBL2393419 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4371979-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT Kumiai Chemical Industry Co., Ltd. (JP) 2024-05-22 EP disclosed
CN-117693500-A Carboxamide derivative and agricultural/horticultural plant disease control agent 组合化学工业株式会社 2024-03-12 CN disclosed
WO-2023286855-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT クミアイ化学工業株式会社 2023-01-19 WO disclosed
EP-1772150-A1 Benzothiophene formulations of a specific dosage Eli Lilly &amp; Company (US) 2007-04-11 EP disclosed
US-20060106010-A1 Methods for inhibiting bone loss ELI LILLY AND COMPANY 2006-05-18 US disclosed
US-RE39049-E1 Methods for inhibiting bone loss ELI LILLY AND COMPANY (US) 2006-03-28 US disclosed
US-RE38968-E1 Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride ELI LILLY AND COMPANY (US) 2006-02-07 US disclosed
US-6906086-B2 Methods for inhibiting bone loss ELI LILLY AND COMPANY (US) 2005-06-14 US disclosed
EP-1438957-A1 Benzothiophene formulations of a specific dosage ELI LILLY AND COMPANY (US) 2004-07-21 EP disclosed
US-20030212058-A1 Methods for inhibiting bone loss ELI LILLY AND COMPANY 2003-11-13 US disclosed
US-5646137-A Combination treatment for osteoporosis ELI LILLY AND COMPANY (US) 1997-07-08 US disclosed
EP-0781555-A1 Benzothiophene formulations of a specific dosage ELI LILLY AND COMPANY (US) 1997-07-02 EP disclosed
EP-0584952-B1 Improvements in or relating to benzothiophenes LILLY CO ELI (US) 1997-05-02 EP disclosed
US-5591753-A BENZOTHIOPHENE DERIVATIVE IN COMBINATION WITH A PROGESTIN ELI LILLY AND COMPANY (US) 1997-01-07 US disclosed
US-5534527-A TREATMENT OF OSTEOPOROSIS ELI LILLY AND COMPANY (US) 1996-07-09 US disclosed
US-5457117-A Method for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B][2-(piperidin-1-yl)ethoxyphenylimethanone hydrochloride ELI LILLY AND COMPANY (US) 1995-10-10 US disclosed
EP-0665015-A2 Combination treatment for osteoporosis ELI LILLY AND COMPANY (US) 1995-08-02 EP disclosed
US-5393763-A Administering benzothiophenes such as raloxifene hydrochloride ELI LILLY AND COMPANY (US) 1995-02-28 US disclosed
EP-0584952-A1 Improvements in or relating to benzothiophenes ELI LILLY AND COMPANY (US) 1994-03-02 EP disclosed